{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:33:39Z","timestamp":1761597219478,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Drug Metab. Pharmacokinet."],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1007\/bf03190025","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T02:01:31Z","timestamp":1280887291000},"page":"233-236","source":"Crossref","is-referenced-by-count":2,"title":["Urinary excretion of phenobarbital and its metabolitep-hydroxyphenobarbital in convulsing and non-convulsing patients"],"prefix":"10.1007","volume":"24","author":[{"given":"B.","family":"Brzakovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Pokrajac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dzoljic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Levic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. M.","family":"Varagic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03190025_CR1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1212\/WNL.38.2.202","volume":"38","author":"D.M. Shaner","year":"1988","unstructured":"Shaner D.M., McCurdy S.A., Herring M.O., Gabor A.J. (1988): Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology, 38: 202\u2013207.","journal-title":"Neurology"},{"key":"BF03190025_CR2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1542\/peds.75.6.1061","volume":"75","author":"S.M. Donn","year":"1985","unstructured":"Donn S.M., Grasela T.M., Goldstein G.W. (1985): Safety of a higher loading dose in the term newborn. Pediatrics, 75: 1061\u20131064.","journal-title":"Pediatrics"},{"key":"BF03190025_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0090-9556(25)05906-9","volume":"5","author":"M.P. Whyte","year":"1977","unstructured":"Whyte M.P., Dekaban A.S. (1977): Metabolic fate of phenobarbital: a quantatative study of p-hydroxyphenobarbital elimination in man. Drug Metab. Dispos., 5: 63\u201370.","journal-title":"Drug Metab. Dispos."},{"key":"BF03190025_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-4347(00)84590-9","volume":"343","author":"V.O. Bhargava","year":"1985","unstructured":"Bhargava V.O., Soine W.H., Garrettson L.K. (1985): High-performance liquid chromatographic analysis of 1-(beta-d-glucopyranosil)phenobarbital in urine. J. Chromatogr. Biomed. Appl., 343: 219\u2013223.","journal-title":"J. Chromatogr. Biomed. Appl."},{"key":"BF03190025_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0022-3565(25)11275-5","volume":"192","author":"T.C. Butler","year":"1954","unstructured":"Butler T.C., Mahafee C., Wadell W.J. (1954): Phenobarbital: studies of elimination, accumulation, tolerance and dosage schedules. J. Pharmacol. Exp. Ther., 192: 425\u2013235.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03190025_CR6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0022-3565(25)30049-2","volume":"192","author":"J. Alvin","year":"1975","unstructured":"Alvin J., McHorse T., Hoyumpa A., Bush M.T., Schenker S.E. (1975): The effect of liver disease in man on the disposition of phenobarbital. J. Pharmacol. Exp. Ther., 192: 224\u2013435.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BF03190025_CR7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/clpt.1981.66","volume":"29","author":"I.M. Kapetanovic","year":"1981","unstructured":"Kapetanovic I.M., Kupferberg H.J., Porter R.J., Theodore W., Schulman E., Penry J.K. (1981): Mechanism of valproate-phenobarbital interaction in epileptic patients. Clin. Pharmacol. Ther., 29: 480\u2013486.","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl. 1","key":"BF03190025_CR8","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1111\/j.1528-1157.1985.tb05725.x","volume":"26","author":"R.P. Simon","year":"1985","unstructured":"Simon R.P. (1985): Physiologic consequences of status epilepticus. Epilepsia, 26 (Suppl. 1): S58-S66.","journal-title":"Epilepsia"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03190025\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T19:33:57Z","timestamp":1740339237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03190025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["BF03190025"],"URL":"https:\/\/doi.org\/10.1007\/bf03190025","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}